Crewe Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-85
Closed -$2.9K 1034
2024
Q1
$2.9K Buy
+85
New +$2.9K ﹤0.01% 820